Connect with us
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
Rovi obtained a gross operating result of €279 million in 2022. Sales of the heparin division increased by 9% in 2022 compared to 2021, up to...
Pfizer closed the first quarter of 2022 with a profit of $7.86 billion, up from $4.88 billion collected between January and March 2021. The pharma developer...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
Valneva will soon be able to sell its Covid-19 vaccine candidate. On the European side, Valneva has broken off negotiations with the European Commission, preferring bilateral...
Rovi will start producing Moderna's COVID-19 vaccine in Andalusia. This investment consists of the installation of a new line to support the production phases of the...
If the stock and bond prices are already crashing due to inflation (while the Fed Funds Rate is already at 0% and QE is at a...
Once the ISS gives the approval and as soon as the bureaucratic process is completed, the first grams of vaccine will be injected to 80 volunteers....
The results of the clinical trials conducted by Moderna, showed that its COVID-19 vaccine candidate is very efficient. In the group age 18 -64, the efficacy...
The US company Moderna with its mRNA-based COVID-19 vaccine is currently the best-known example of how biotech companies are making progress for society. In addition to...